['dry eye syndromes']
['cyclosporine a', 'placebo']

        Inclusion Criteria:

          -  Signed Informed Consent Form and HIPAA (Health Insurance Portability and
             Accountability Act ) document

          -  Patient-reported history of dry eye in both eyes

          -  Current use of over-the-counter and/or prescription eye drops for dry eye symptoms

          -  Ability and willingness to follow instructions, including participation in all study
             assessments and visits

        Exclusion Criteria:

          -  Women who are pregnant, nursing or planning a pregnancy

          -  Unwillingness to submit a blood pregnancy test at screening and at the last visit (or
             early termination visit) if of childbearing potential, or unwillingness to use
             acceptable means of birth control

          -  Clinically significant slit-lamp findings or abnormal lid anatomy at screening

          -  DED secondary to scarring or ocular or periocular malignancy

          -  History of herpetic keratitis

          -  Active ocular allergies or ocular allergies that are expected to be active during the
             study period

          -  Ongoing ocular or systemic infection at screening or baseline

          -  Wear of contact lenses within 3 months prior to screening or anticipated use of
             contact lenses during the study

          -  History of no response to previous topical Cyclosporine A and/or use of topical
             Cyclosporine A within 6 months prior to screening

          -  Intra-ocular surgery or ocular laser surgery within the previous 6 months, or have any
             planned ocular and/or lid surgeries over the study period

          -  Presence of an uncontrolled systemic disease

          -  Presence of a known allergy and/or sensitivity to the study drug or its components
      